[Federal Register: February 7, 2003 (Volume 68, Number 26)]
[Notices]               
[Page 6515]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07fe03-115]                         


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE


Drug Enforcement Administration


 
Manufacturer of Controlled Substances: Notice of Registration


    By Notice dated October 21, 2002, and published in the Federal 
Register on October 25, 2002, (67 FR 65604), Rhodes Technologies, 498 
Washington Street, Conventry, Rhode Island 02816, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:


------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................  I
Dihydrocodeine (9120).......................  II
Hydromorphone (9150)........................  II
Hydrocodone (9193)..........................  II
Noroxymorphone (9668).......................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------


    The firm plans to produce bulk product for conversion and 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Rhodes Technologies to manufacture 
the listed controlled substances is consistent with the public interest 
at this time.
    DEA has investigated Rhodes Technologies to ensure that the 
company's registration is consistent with the public interest. This 
investigation included inspection and testing of the company's physical 
security systems, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.


    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-3053 Filed 2-6-03; 8:45 am]

BILLING CODE 4410-09-M